S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
MarketBeat Week in Review – 6/4 - 6/9
BREAKING: Tiny biotech successfully treats blindness (Ad)
How major US stock indexes fared Friday 6/9/2023
FuelCell Is Back To Realistic Valuation
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
New Mexico reaches $500M settlement with Walgreens in opioid case
With GM and Ford embracing Tesla's EV charging technology, here's what it means for consumers
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
Nigeria's central bank chief arrested after being suspended by president
Closing prices for crude oil, gold and other commodities
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
MarketBeat Week in Review – 6/4 - 6/9
BREAKING: Tiny biotech successfully treats blindness (Ad)
How major US stock indexes fared Friday 6/9/2023
FuelCell Is Back To Realistic Valuation
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
New Mexico reaches $500M settlement with Walgreens in opioid case
With GM and Ford embracing Tesla's EV charging technology, here's what it means for consumers
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
Nigeria's central bank chief arrested after being suspended by president
Closing prices for crude oil, gold and other commodities
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
MarketBeat Week in Review – 6/4 - 6/9
BREAKING: Tiny biotech successfully treats blindness (Ad)
How major US stock indexes fared Friday 6/9/2023
FuelCell Is Back To Realistic Valuation
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
New Mexico reaches $500M settlement with Walgreens in opioid case
With GM and Ford embracing Tesla's EV charging technology, here's what it means for consumers
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
Nigeria's central bank chief arrested after being suspended by president
Closing prices for crude oil, gold and other commodities
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
MarketBeat Week in Review – 6/4 - 6/9
BREAKING: Tiny biotech successfully treats blindness (Ad)
How major US stock indexes fared Friday 6/9/2023
FuelCell Is Back To Realistic Valuation
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
New Mexico reaches $500M settlement with Walgreens in opioid case
With GM and Ford embracing Tesla's EV charging technology, here's what it means for consumers
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
Nigeria's central bank chief arrested after being suspended by president
Closing prices for crude oil, gold and other commodities
NASDAQ:NXGN

NextGen Healthcare (NXGN) Stock Forecast, Price & News

$16.26
+0.02 (+0.12%)
(As of 06/9/2023 ET)
Compare
Today's Range
$16.22
$16.71
50-Day Range
$15.35
$18.06
52-Week Range
$15.23
$21.99
Volume
306,305 shs
Average Volume
439,853 shs
Market Capitalization
$1.07 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$21.20

NextGen Healthcare MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.50 Rating Score
Upside/​Downside
30.4% Upside
$21.20 Price Target
Short Interest
Bearish
6.63% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
1.31mentions of NextGen Healthcare in the last 14 days
Based on 5 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
33.33%
From $0.66 to $0.88 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.19 out of 5 stars

Medical Sector

340th out of 987 stocks

Computer Integrated Systems Design Industry

17th out of 33 stocks


NXGN stock logo

About NextGen Healthcare (NASDAQ:NXGN) Stock

NextGen Healthcare, Inc. provides software and services that empower ambulatory healthcare practices to manage the risk and complexity of delivering care in the rapidly evolving U.S. healthcare system. Its portfolio includes tightly integrated solutions that deliver on ambulatory healthcare imperatives including population health, care management, patient outreach, telemedicine, and nationwide clinical information exchange. The company was founded by Sheldon Razin in 1974 and is headquartered in Irvine, CA.

Receive NXGN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NextGen Healthcare and its competitors with MarketBeat's FREE daily newsletter.

NXGN Stock News Headlines

[BREAKING] New "Living Missile" to Replace Nuclear Missiles
CBS News Reports: "It's an entirely new type of weapon." The New York Times Reports: "No existing defense can stop it." And one small company is building them for the Pentagon!
NextGen Healthcare (NASDAQ:NXGN) Price Target Cut to $18.00
66,000% upside on tiny biotech?
The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.
The Latest Analyst Ratings for NextGen Healthcare
NextGen Healthcare (NASDAQ: NXGN)
Q4 2023 NextGen Healthcare Inc Earnings Call
NextGen Healthcare Q4 2023 Earnings Preview
See More Headlines

NXGN Price History

NXGN Company Calendar

Last Earnings
5/16/2023
Today
6/10/2023
Next Earnings (Estimated)
7/25/2023
Fiscal Year End
3/31/2024

Industry, Sector and Symbol

Industry
Computer integrated systems design
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:NXGN
Employees
2,783
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$21.20
High Stock Price Forecast
$25.00
Low Stock Price Forecast
$17.00
Forecasted Upside/Downside
+30.4%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
4 Analysts

Profitability

Net Income
$-2,650,000.00
Pretax Margin
0.66%

Debt

Sales & Book Value

Annual Sales
$653.17 million
Cash Flow
$1.17 per share
Book Value
$6.07 per share

Miscellaneous

Free Float
63,012,000
Market Cap
$1.07 billion
Optionable
Optionable
Beta
1.02

Key Executives

  • David William SidesDavid William Sides
    President, Chief Executive Officer & Director
  • L. Allen Plunk
    Executive Vice President-Operations
  • James R. Arnold
    Chief Financial Officer & Executive Vice President
  • Robert L. Murry
    Chief Medical Officer
  • David Slazyk
    Chief Information & Security Officer













NXGN Stock - Frequently Asked Questions

Should I buy or sell NextGen Healthcare stock right now?

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for NextGen Healthcare in the last twelve months. There are currently 2 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" NXGN shares.
View NXGN analyst ratings
or view top-rated stocks.

What is NextGen Healthcare's stock price forecast for 2023?

4 brokers have issued 12-month target prices for NextGen Healthcare's stock. Their NXGN share price forecasts range from $17.00 to $25.00. On average, they expect the company's share price to reach $21.20 in the next year. This suggests a possible upside of 30.4% from the stock's current price.
View analysts price targets for NXGN
or view top-rated stocks among Wall Street analysts.

How have NXGN shares performed in 2023?

NextGen Healthcare's stock was trading at $18.78 at the start of the year. Since then, NXGN shares have decreased by 13.4% and is now trading at $16.26.
View the best growth stocks for 2023 here
.

When is NextGen Healthcare's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, July 25th 2023.
View our NXGN earnings forecast
.

How were NextGen Healthcare's earnings last quarter?

NextGen Healthcare, Inc. (NASDAQ:NXGN) announced its earnings results on Tuesday, May, 16th. The company reported $0.23 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.18 by $0.05. The business earned $178.55 million during the quarter, compared to analysts' expectations of $170.61 million. NextGen Healthcare had a negative net margin of 0.41% and a positive trailing twelve-month return on equity of 8.51%.

What guidance has NextGen Healthcare issued on next quarter's earnings?

NextGen Healthcare updated its FY 2024 earnings guidance on Friday, May, 26th. The company provided EPS guidance of $1.04-$1.11 for the period, compared to the consensus EPS estimate of $1.10. The company issued revenue guidance of $712.00 million-$722.00 million, compared to the consensus revenue estimate of $709.32 million.

What is Rusty Frantz's approval rating as NextGen Healthcare's CEO?

248 employees have rated NextGen Healthcare Chief Executive Officer Rusty Frantz on Glassdoor.com. Rusty Frantz has an approval rating of 72% among the company's employees.

What other stocks do shareholders of NextGen Healthcare own?

Based on aggregate information from My MarketBeat watchlists, some companies that other NextGen Healthcare investors own include Altria Group (MO), Verizon Communications (VZ), Exxon Mobil (XOM), Best Buy (BBY), Enbridge (ENB), Enterprise Products Partners (EPD), Huntington Bancshares (HBAN), Netflix (NFLX), Tapestry (TPR) and Twitter (TWTR).

What is NextGen Healthcare's stock symbol?

NextGen Healthcare trades on the NASDAQ under the ticker symbol "NXGN."

Who are NextGen Healthcare's major shareholders?

NextGen Healthcare's stock is owned by many different retail and institutional investors. Top institutional shareholders include BlackRock Inc. (14.26%), Dimensional Fund Advisors LP (3.66%), State Street Corp (2.99%), William Blair Investment Management LLC (2.34%), Alyeska Investment Group L.P. (1.76%) and Geode Capital Management LLC (1.68%). Insiders that own company stock include Craig A Barbarosh, David A Metcalfe, David Ahmadzai, David William Sides, Donna Cullen Greene, George H Bristol, James Robert Jr Arnold, John R Frantz, Lance Rosenzweig, Mitchell Waters, Sean Brynjelsen and Srinivas S Velamoor.
View institutional ownership trends
.

How do I buy shares of NextGen Healthcare?

Shares of NXGN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is NextGen Healthcare's stock price today?

One share of NXGN stock can currently be purchased for approximately $16.26.

How much money does NextGen Healthcare make?

NextGen Healthcare (NASDAQ:NXGN) has a market capitalization of $1.07 billion and generates $653.17 million in revenue each year. The company earns $-2,650,000.00 in net income (profit) each year or ($0.04) on an earnings per share basis.

How many employees does NextGen Healthcare have?

The company employs 2,783 workers across the globe.

How can I contact NextGen Healthcare?

NextGen Healthcare's mailing address is 18111 Von Karman Avenue Suite 800, Irvine CA, 92612. The official website for the company is www.nextgen.com. The company can be reached via phone at (949) 255-2600, via email at ir@nextgen.com, or via fax at 949-255-2605.

This page (NASDAQ:NXGN) was last updated on 6/10/2023 by MarketBeat.com Staff

My Account -